GREY:IMVIF - Post by User
Post by
Breakthorough1on Jun 04, 2023 3:57pm
276 Views
Post# 35479366
FDA new accelerated approval (May 19th)
FDA new accelerated approval (May 19th) The response rate is similar to that of DPX in February. But the toxicity is much much higher. It's reslly absurd not to give a chance to DPX:
https://www.fda.gov/drugs/drug-approvals-and-databases/fda-grants-accelerated-approval-epcoritamab-bysp-relapsed-or-refractory-diffuse-large-b-cell